Skip to main content
Erschienen in: Annals of Hematology 1/2004

01.01.2004 | Case Report

Successful labor in the course of chronic lymphocytic leukemia (CLL) and management of CLL during pregnancy with leukapheresis

verfasst von: R. Ali, F. Özkalemkaş, V. Özkocaman, E. Bülbül-Başkan, T. Özçelik, Ü. Ozan, Y. Kimya, A. Tunalı

Erschienen in: Annals of Hematology | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

We describe the successful management of a 30-year-old woman in the second trimester of her pregnancy with chronic lymphocytic leukemia (CLL) in stage IV by using only leukapheresis. We applied three sessions (courses) of leukapheresis throughout the pregnancy. The procedure did not have any significant adverse effect on the patient and the fetus. The patient gave birth vaginally to a healthy boy, weighing 3100 g, at 39 weeks of gestation. Seven months after delivery, Richter's syndrome developed in the patient. We conclude that leukapheresis may provide an alternative for palliative treatment to chemotherapy in pregnant patients with CLL. To our knowledge, this is the fourth reported case of CLL in pregnancy, and the first management of CLL during pregnancy with leukapheresis.
Literatur
1.
Zurück zum Zitat Johnston JB (1999) Chronic lymphocytic leukemia. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (eds) Wintrobe's Clinical Hematology. Mass Publishing Co, Giza Egypt, pp 2405 Johnston JB (1999) Chronic lymphocytic leukemia. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (eds) Wintrobe's Clinical Hematology. Mass Publishing Co, Giza Egypt, pp 2405
2.
Zurück zum Zitat Hamblin TJ (2001) Achieving optimal outcomes in chronic lymphocytic leukaemia. Drugs 61:593–611PubMed Hamblin TJ (2001) Achieving optimal outcomes in chronic lymphocytic leukaemia. Drugs 61:593–611PubMed
3.
Zurück zum Zitat Kalil N, Cheson BD (2000) Management of chronic lymphocytic leukaemia. Drugs Aging 16:9–27PubMed Kalil N, Cheson BD (2000) Management of chronic lymphocytic leukaemia. Drugs Aging 16:9–27PubMed
4.
Zurück zum Zitat de Lima M, O'Brien S, Lerner S, Keating MJ (1998) Chronic lymphocytic leukemia in the young patient. Semin Oncol 25:107–116 de Lima M, O'Brien S, Lerner S, Keating MJ (1998) Chronic lymphocytic leukemia in the young patient. Semin Oncol 25:107–116
5.
Zurück zum Zitat Mauro FR, Foa R, Giannarelli D, Cordone L, Crescensi S, Pescarmona E, Sala R, Cerretti R, Mandelli F (1999) Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 94:448–454PubMed Mauro FR, Foa R, Giannarelli D, Cordone L, Crescensi S, Pescarmona E, Sala R, Cerretti R, Mandelli F (1999) Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 94:448–454PubMed
6.
Zurück zum Zitat Chrisomalis L, Baxi LV, Heller D (1996) Chronic lymphocytic leukemia in pregnancy. Am J Obstet Gynecol 175:1381–1382PubMed Chrisomalis L, Baxi LV, Heller D (1996) Chronic lymphocytic leukemia in pregnancy. Am J Obstet Gynecol 175:1381–1382PubMed
7.
Zurück zum Zitat Welsh TM, Thompson J, Lim S (2000) Chronic lymphocytic leukemia in pregnancy. Leukemia 14:1155CrossRefPubMed Welsh TM, Thompson J, Lim S (2000) Chronic lymphocytic leukemia in pregnancy. Leukemia 14:1155CrossRefPubMed
8.
Zurück zum Zitat Gurman G (2002) Pregnancy and successful labor in the course of chronic lymphocytic leukemia. Am J Hematol 71:208–210CrossRefPubMed Gurman G (2002) Pregnancy and successful labor in the course of chronic lymphocytic leukemia. Am J Hematol 71:208–210CrossRefPubMed
9.
Zurück zum Zitat Owen HG, Brecher ME (1997) Management of the therapeutic apheresis patient. In: McLeod BC (ed) Apheresis: Principles and Practice. AABB Press, Maryland pp 223–249 Owen HG, Brecher ME (1997) Management of the therapeutic apheresis patient. In: McLeod BC (ed) Apheresis: Principles and Practice. AABB Press, Maryland pp 223–249
10.
Zurück zum Zitat Dighiero G, Binet JL (2000) When and how to treat chronic lymphocytic leukemia. N Engl J Med 343:1799–1801CrossRefPubMed Dighiero G, Binet JL (2000) When and how to treat chronic lymphocytic leukemia. N Engl J Med 343:1799–1801CrossRefPubMed
11.
Zurück zum Zitat Keating MJ (1999) Chronic lymphocytic leukemia. Semin Oncol 26:107–114 Keating MJ (1999) Chronic lymphocytic leukemia. Semin Oncol 26:107–114
12.
Zurück zum Zitat Robak T, Kasznicki M (2002) Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 16:1015–1027CrossRefPubMed Robak T, Kasznicki M (2002) Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 16:1015–1027CrossRefPubMed
13.
Zurück zum Zitat Jacobs P, Wood L (2002) Chronic lymphocytic leukemia-the hematologic basis for diagnosis and treatment. Hematology 7:33–41CrossRefPubMed Jacobs P, Wood L (2002) Chronic lymphocytic leukemia-the hematologic basis for diagnosis and treatment. Hematology 7:33–41CrossRefPubMed
14.
Zurück zum Zitat Rai KR, Döhner H, Keating MJ, Montserrat E (2001) Chronic lymphocytic leukemia: case-based session. Hematology (Am Soc Hematol Educ Program) 140–156 Rai KR, Döhner H, Keating MJ, Montserrat E (2001) Chronic lymphocytic leukemia: case-based session. Hematology (Am Soc Hematol Educ Program) 140–156
15.
Zurück zum Zitat Ebert U, Löffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74:207–220CrossRefPubMed Ebert U, Löffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74:207–220CrossRefPubMed
16.
Zurück zum Zitat Turchi JJ, Villasis C (1988) Anthracyclines in the treatment of malignancy in pregnancy. Cancer 61:435–440PubMed Turchi JJ, Villasis C (1988) Anthracyclines in the treatment of malignancy in pregnancy. Cancer 61:435–440PubMed
17.
Zurück zum Zitat Doll DC, Ringenberg S, Yarbro JW (1988) Management of cancer during pregnancy. Arch Intern Med 148:2058–2064PubMed Doll DC, Ringenberg S, Yarbro JW (1988) Management of cancer during pregnancy. Arch Intern Med 148:2058–2064PubMed
18.
Zurück zum Zitat Buerkers TE, Lallas TA (1998) Chemotherapy in pregnancy. Obstet Gynecol Clin North Am 25:323–329PubMed Buerkers TE, Lallas TA (1998) Chemotherapy in pregnancy. Obstet Gynecol Clin North Am 25:323–329PubMed
19.
Zurück zum Zitat Garcia L, Valcarcel M, Santiago-Borrero PJ (1999) Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two cases reports. J Perinatol 19:230–233CrossRefPubMed Garcia L, Valcarcel M, Santiago-Borrero PJ (1999) Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two cases reports. J Perinatol 19:230–233CrossRefPubMed
20.
Zurück zum Zitat Patsner B, Penney RW, Walsh C (1994) Recurrent hairy cell leukemia during pregnancy: a case report. Am J Obstet Gynecol 170:1380–1381PubMed Patsner B, Penney RW, Walsh C (1994) Recurrent hairy cell leukemia during pregnancy: a case report. Am J Obstet Gynecol 170:1380–1381PubMed
21.
Zurück zum Zitat Alothman A (1994) Managing hairy cell leukemia in pregnancy. Ann Intern Med 120:1048–1049 Alothman A (1994) Managing hairy cell leukemia in pregnancy. Ann Intern Med 120:1048–1049
22.
Zurück zum Zitat Williams JK (1987) Hairy cell leukemia in pregnancy: a case report. Am J Obstet Gynecol 156:210–211PubMed Williams JK (1987) Hairy cell leukemia in pregnancy: a case report. Am J Obstet Gynecol 156:210–211PubMed
23.
Zurück zum Zitat Baer MR, Ozer H, Foon KA (1992) Interferon-α therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol 81:167–169PubMed Baer MR, Ozer H, Foon KA (1992) Interferon-α therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol 81:167–169PubMed
24.
Zurück zum Zitat Feliu J, Juarez S, Ordonez A, Garcia-Paredes LM, Gonzalez-Baron M, Montero JM (1988) Acute leukemia and pregnancy. Cancer 61:580–584PubMed Feliu J, Juarez S, Ordonez A, Garcia-Paredes LM, Gonzalez-Baron M, Montero JM (1988) Acute leukemia and pregnancy. Cancer 61:580–584PubMed
25.
Zurück zum Zitat Peleg D, Ben-Ami M (1998) Lymphoma and leukemia complicating pregnancy. Obstet Gynecol Clin North Am 25:365–383PubMed Peleg D, Ben-Ami M (1998) Lymphoma and leukemia complicating pregnancy. Obstet Gynecol Clin North Am 25:365–383PubMed
26.
Zurück zum Zitat Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173–177PubMed Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173–177PubMed
27.
Zurück zum Zitat Ali R, Özkalemkaş F, Özçelik T, Özkocaman V, Ozan Ü, Kimya Y, Tunalı A (2003) Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res 27:381–385CrossRefPubMed Ali R, Özkalemkaş F, Özçelik T, Özkocaman V, Ozan Ü, Kimya Y, Tunalı A (2003) Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res 27:381–385CrossRefPubMed
28.
Zurück zum Zitat Bazarbashi MS, Smith MR, Karanes C, Zielinski I, Bishop CR (1991) Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy. Am J Hematol 38:235–237PubMed Bazarbashi MS, Smith MR, Karanes C, Zielinski I, Bishop CR (1991) Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy. Am J Hematol 38:235–237PubMed
29.
Zurück zum Zitat Juarez S, Cuadrado-Pastor JM, Feliu J, Gonzalez-Baron M, Ordonez A, Montero JM (1988) Association of leukemia and pregnancy: clinical and obstetric aspects. Am J Clin Oncol 11:159–165 Juarez S, Cuadrado-Pastor JM, Feliu J, Gonzalez-Baron M, Ordonez A, Montero JM (1988) Association of leukemia and pregnancy: clinical and obstetric aspects. Am J Clin Oncol 11:159–165
30.
Zurück zum Zitat Arulkumaran S, Koh CH, Pang M, Ding ZP, Ratnam SS (1987) Chronic myeloid leukemia presenting as a gynecological emergency. Gynecol Oncol 28:111–115PubMed Arulkumaran S, Koh CH, Pang M, Ding ZP, Ratnam SS (1987) Chronic myeloid leukemia presenting as a gynecological emergency. Gynecol Oncol 28:111–115PubMed
31.
Zurück zum Zitat Hester J (1997) Therapeutic cell depletion. In: McLeod BC, Price TH, Drew MJ (eds) Apheresis: Principles and Practice. AABB Press, Bethesda MD, pp 251 Hester J (1997) Therapeutic cell depletion. In: McLeod BC, Price TH, Drew MJ (eds) Apheresis: Principles and Practice. AABB Press, Bethesda MD, pp 251
32.
Zurück zum Zitat Fitzgerald D, Rowe JM, Heal J (1986) Leukapheresis for control of chronic myelogenous leukemia during pregnancy. Am J Hematol 22:213–218PubMed Fitzgerald D, Rowe JM, Heal J (1986) Leukapheresis for control of chronic myelogenous leukemia during pregnancy. Am J Hematol 22:213–218PubMed
33.
Zurück zum Zitat Strobl FJ, Voelkerding KV, Smith EP (1999) Management of chronic myeloid leukemia during pregnancy with leukapheresis. J Clin Apheresis 14:42–44CrossRefPubMed Strobl FJ, Voelkerding KV, Smith EP (1999) Management of chronic myeloid leukemia during pregnancy with leukapheresis. J Clin Apheresis 14:42–44CrossRefPubMed
34.
Zurück zum Zitat Giles FJ, O'Brien SM, Keating MJ (1998) Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 25:117–125 Giles FJ, O'Brien SM, Keating MJ (1998) Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 25:117–125
35.
Zurück zum Zitat Robak T, Urbanska-Rys, Strzelecka B, Krykowski E, Bartkowiak J, Blonski JZ, Kordek R, Warzocha K (2001) Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. Eur J Haematol 67:322–327CrossRefPubMed Robak T, Urbanska-Rys, Strzelecka B, Krykowski E, Bartkowiak J, Blonski JZ, Kordek R, Warzocha K (2001) Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. Eur J Haematol 67:322–327CrossRefPubMed
Metadaten
Titel
Successful labor in the course of chronic lymphocytic leukemia (CLL) and management of CLL during pregnancy with leukapheresis
verfasst von
R. Ali
F. Özkalemkaş
V. Özkocaman
E. Bülbül-Başkan
T. Özçelik
Ü. Ozan
Y. Kimya
A. Tunalı
Publikationsdatum
01.01.2004
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 1/2004
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0723-0

Weitere Artikel der Ausgabe 1/2004

Annals of Hematology 1/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.